Rather than guessing whether sermorelin and semaglutide work together in your body, precision testing identifies your peptide-pathway genetic profile before treatment starts
Retatrutide is not yet FDA-approved for obesity treatment as of October 2025
A trial published in the New England Journal of Medicine found that participants using tirzepatide lost up to 20.9% of their body weight over 72 weeks, with results improving progressively at higher doses across all treatment groups (Jastreboff et al., NEJM, 2022, Michigan residents across the state, from Detroit to the Upper Peninsula, have real and practical access to tirzepatide today
What can change over time is the metabolic environment those mechanisms operate within
PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) across all commitment tiers, with no insurance required and HSA/FSA eligibility
healthline.com 10Jastreboff A.M